Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 72, 2018 - Issue 2
Submit an article Journal homepage
407
Views
12
CrossRef citations to date
0
Altmetric
Original Article

The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder

Dragana Ignjatović RistićPsychiatric Clinic, Clinical Center Kragujevac and Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia; View further author information
,
Dan CohenDepartment of Community Mental Health, Mental Health Care North-Holland North, Heerhugowaard, Netherlands; View further author information
,
Andrea ObradovićPsychiatric Clinic, Clinical Center Kragujevac and Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia; View further author information
,
Katarina Nikić-ĐuričićPsychiatric Clinic, Clinical Center Kragujevac and Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia; View further author information
,
Marija DraškovićPsychiatric Clinic, Clinical Center Kragujevac and Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia; View further author information
&
Darko HinićFaculty of Science and Faculty of Philology and Arts, University of Kragujevac, Kragujevac, SerbiaCorrespondence[email protected]
View further author information
Pages 124-129 | Received 27 Apr 2017, Accepted 27 Oct 2017, Published online: 10 Nov 2017

References

  • Erlandsen C. Clozapine for schizophrenia. Clinical effect, financial considerations, and quality requirements. Nord J Psychiatry. 2000;54:143–148.
  • Samara MT, Dold M, Gianatsi M, et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry. 2016;73:199–210.
  • Kane JM, Correll CU. The role of clozapine in treatment-resistant schizophrenia. JAMA Psychiatry. 2016;73:187–188.
  • Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951–962.
  • Cohen D. Prescribers fear as a major side-effect of clozapine. Acta Psychiatr Scand. 2014;130:154–159.
  • Marinković D, Timotijević I, Babinski T, et al. The side-effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:537–544.
  • Takeuchi I, Hanya M, Uno J, et al. A Questionnaire-based study of the views of schizophrenia patients and psychiatric healthcare professionals in Japan about the side effects of clozapine. Clin Psychopharmacol Neurosci. 2016;14:286–294.
  • Day JC, Wood G, Dewey M, et al. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166:650–653.
  • Hynes C, Keating D, McWilliams S, et al. Glasgow antipsychotic side-effects scale for clozapine - development and validation of a clozapine-specific side-effects scale. Schizophr Res. 2015;168:505–513.
  • Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, adherence and other clinical variables. Int Clin Psychopharmacol. 1995;10(3):133–138.
  • Seppälä N, Leinonen E, Viikki M, et al. Factors associated with subjective side-effects during clozapine treatment. Nord J Psychiatry. 2015;69:161–166.
  • Yusufi B, Mukherjee S, Flanagan R, et al. Prevalence and nature of side-effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol. 2007;22:238–243.
  • Bersani FS, Capra E, Minichino A, et al. Factors affecting interindividual differences in clozapine response: a review and case report. Hum Psychopharmacol. 2011;26:177–187.
  • Bogers JP, Schulte PF, VanDijk D, et al. Clozapine underutilization in the treatment of schizophrenia. How can clozapine prescription rates be improved? J Clin Psychopharmacol. 2016;36:109–111.
  • Hodge K, Jespersen S. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians. Int J Ment Health Nurs. 2009;17:2–8.
  • Legge SE, Hamshere M, Hayes RD, et al. Reasons for discontinuing clozapine: a cohort study of patients commencing treatment. Schizophr Res. 2016;174:113–119.
  • Lindström E, Lewander T, Malm U, et al. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Nord J Psychiatry. 2001;55(44):5–69.
  • Nielsen J, Dahm M, Lublin H, et al. Psychiatrists’ attitude towards and knowledge of clozapine treatment. J Psychopharmacol (Oxford). 2010;24:965–971.
  • Anderson SG, Livingston M, Couchman L, et al. Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey. Ann Gen Psychiatry. 2015;14:39.
  • Rostami-Hodjegan A, Amin AM, Spencer EP, et al. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. J Clin Psychopharmacol. 2004;24:70–78.
  • Flanagan RJ. Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf. 2008;3:115–122.
  • Taylor DM, Douglas-Hall P, Olofinjana B, et al. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry. 2009;194:165–176.
  • Cohen D, Bogers JPAM, van Dijk D, et al. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry. 2012;73:1307–1312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.